Vitruvias Therapeutics Inc. announced a voluntary recall of one lot (Lot No. 504950) of Thyroid Tablets, USP 30 mg, which was ...

A nationwide recall was issued for this common thyroid medication. See the recalled products.

A thyroid medication recall affects 30-milligram tablets due to potential superpotency concerns. Superpotency can cause ...

The Food and Drug Administration announced a recall for one lot of Vitruvias Therapeutics Inc.'s thyroid tablets as they are ...

Vitruvias Therapeutics has “ceased operations” after voluntarily recalling a batch recall of generic thyroid tablets due to ...

Less than a month after initiating a drug recall after cardboard was fou | Baxter has initiated a recall of two products ...

The superpotnent medication can cause major heath problems such as muscle weakness, hypertension, chest pain, rapid heart ...

Vitruvias Therapeutics is recalling one lot of Thyroid Tablets, USP 30 mg because testing found the medication may be ...

A widely used thyroid medication is being recalled nationwide after testing found the tablets didn’t contain enough of their active ingredient. The recall was classified by the U.S. Food and Drug ...

Vitruvias Therapeutics is recalling one lot of Thyroid Tablets, USP 30 mg, distributed nationwide after testing found the ...

The drug company said it was arranging for the recalled tablets to be destroyed, but warned patients to not stop taking the ...